About Cidara Therapeutics
Cidara Therapeutics is a company based in San Diego (United States) founded in 2013 was acquired by Merck in November 2025.. Cidara Therapeutics has raised $78.35 million across 8 funding rounds from investors including Merck, Fidelity Investments and NIH. The company has 38 employees as of December 31, 2024. Cidara Therapeutics offers products and services including Cloudbreak Platform. Cidara Therapeutics operates in a competitive market with competitors including BeiGene, Biological E, Vir Biotechnology, BioNTech and Freeline, among others.
- Headquarter San Diego, United States
- Employees 38 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cidara Therapeutics, Inc.
-
Annual Revenue
$1.27 M-94.52as on Dec 31, 2024
-
Net Profit
$-168.03 M-632.75as on Dec 31, 2024
-
EBITDA
$-90.99 M-237.71as on Dec 31, 2024
-
Total Equity Funding
$78.35 M (USD)
in 8 rounds
-
Latest Funding Round
$105 M (USD), Post-IPO
Nov 21, 2024
-
Investors
Merck
& 23 more
-
Employee Count
38
as on Dec 31, 2024
-
Acquired by
Merck
(Nov 14, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Cidara Therapeutics
Cidara Therapeutics is a publicly listed company on the NASDAQ with ticker symbol CDTX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Cidara Therapeutics
Cidara Therapeutics offers a comprehensive portfolio of products and services, including Cloudbreak Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform creates drug-Fc conjugates for targeted disease treatment.
Unlock access to complete
Unlock access to complete
Funding Insights of Cidara Therapeutics
Cidara Therapeutics has successfully raised a total of $78.35M across 8 strategic funding rounds. The most recent funding activity was a Post-IPO round of $105 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 8
- Last Round Post-IPO — $105.0M
-
First Round
First Round
(16 Jun 2014)
- Investors Count 23
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2024 | Amount | Post-IPO - Cidara Therapeutics | Valuation |
investors |
|
| Apr, 2024 | Amount | Post-IPO - Cidara Therapeutics | Valuation |
investors |
|
| Sep, 2019 | Amount | Post-IPO - Cidara Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cidara Therapeutics
Cidara Therapeutics has secured backing from 24 investors, including venture fund and institutional investors. Prominent investors backing the company include Merck, Fidelity Investments and NIH. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on tech sectors
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
US private equity investments are managed by BVF Partners.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cidara Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cidara Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cidara Therapeutics Comparisons
Competitors of Cidara Therapeutics
Cidara Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BeiGene, Biological E, Vir Biotechnology, BioNTech and Freeline, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of infectious diseases
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics for cancer and other diseases are developed.
|
|
| domain | founded_year | HQ Location |
Gene therapy platform is developed for chronic disease treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cidara Therapeutics
Frequently Asked Questions about Cidara Therapeutics
When was Cidara Therapeutics founded?
Cidara Therapeutics was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Cidara Therapeutics located?
Cidara Therapeutics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Cidara Therapeutics?
Jeffrey Stein is the current CEO of Cidara Therapeutics.
Is Cidara Therapeutics a funded company?
Cidara Therapeutics is a funded company, having raised a total of $78.35M across 8 funding rounds to date. The company's 1st funding round was a Post-IPO of $9.01M, raised on Jun 16, 2014.
How many employees does Cidara Therapeutics have?
As of Dec 31, 2024, the latest employee count at Cidara Therapeutics is 38.
What is the annual revenue of Cidara Therapeutics?
Annual revenue of Cidara Therapeutics is $1.27M as on Dec 31, 2024.
What does Cidara Therapeutics do?
Developer of novel anti-infectives for infectious diseases (bacterial and fungal). Its first product candidate is CD101 IV, an intravenous therapy in phase 1 trials for fungal infections. Besides, it has CD101 topical in the IND-enabling stage for the treatment of acute and recurrent vulvovaginal candidiasis (VVS). It has also developed a proprietary immunotherapy technology platform, Cloudbreak to develop drugs that direct immune cells to eliminate pathogens that cause infectious diseases. Its first Cloudbreak development candidate C001 is for the treatment of invasive aspergillosis.
Who are the top competitors of Cidara Therapeutics?
What products or services does Cidara Therapeutics offer?
Cidara Therapeutics offers Cloudbreak Platform.
Is Cidara Therapeutics publicly traded?
Yes, Cidara Therapeutics is publicly traded on NASDAQ under the ticker symbol CDTX.
Who are Cidara Therapeutics's investors?
Cidara Therapeutics has 24 investors. Key investors include Merck, Fidelity Investments, NIH, RA Capital, and Frazier Healthcare Partners.
What is Cidara Therapeutics's ticker symbol?
The ticker symbol of Cidara Therapeutics is CDTX on NASDAQ.